Hamill John 4
4 · SAVIENT PHARMACEUTICALS INC · Filed Sep 26, 2012
Insider Transaction Report
Form 4
Hamill John
SVP, CFO
Transactions
- Award
Common Stock, $0.01 par value
2012-09-24$2.92/sh+100,000$292,000→ 100,000 total - Award
Option to purchase Common Stock, $0.01 par value
2012-09-24$2.92/sh+250,000$730,000→ 250,000 totalExercise: $2.92From: 2013-09-24Exp: 2022-09-24→ Common Stock, $0.01 par value (250,000 underlying)
Footnotes (2)
- [F1]The right to receive these shares is pursuant to a restricted stock grant that will vest as to 1/3 of the grant on each of the first three anniversaries of the grant date.
- [F2]These stock options will vest and become exercisable as to 1/3 of the grant on each of the first three anniversaries of the grant date.